Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam with intubating laryngeal mask anesthesia in cervical spine injury
ChiCTR2600134416Phase 4Not yet recruiting
- Sponsor
- Ningxia Hui Autonomous Region People's Hospital
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and midazolam in Cervical Trauma (2 arms), sponsored by Ningxia Hui Autonomous Region People's Hospital. Primary endpoint: MUZI score. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Cervical Trauma
Beyond the preview
Go deeper on ChiCTR2600134416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134416.